Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClontarf Regulatory News (CLON)

Share Price Information for Clontarf (CLON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0335
Bid: 0.032
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.003 (9.375%)
Open: 0.0335
High: 0.0335
Low: 0.0335
Prev. Close: 0.0335
CLON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JV HoA on Direct Lithium Ion Extraction in Bolivia

15 Feb 2023 07:00

RNS Number : 9364P
Clontarf Energy PLC
15 February 2023
 

15th February 2023

 

Clontarf Energy plc

("Clontarf" or "the Company")

 

JV HoA on Direct Lithium Ion Extraction Technology in Bolivia.

 

 

Clontarf Energy plc (AIM: CLON) is pleased to announce a heads of agreement around the potential formation of a 50:50 Joint Venture with US based, OTC Markets traded, technology company, NEXT-ChemX Corporation ("NCX") covering testing, marketing, and deploying of NCX's proprietary (patent pending) direct lithium ion extraction ("DLE") technology in Bolivia. Formation of the JV is subject to final due diligence and the parties entering into formal documentation, which is intended to occur within the next 30 days.

 

NCX's ion extraction technology uses the surface area of hollow fibre membranes to extract lithium ions from brines. The technology is a continuous process, and does not require high pressure, temperature or electrolysis. It does not rely on osmotic processes, or costly filtration techniques electrolysis, but instead mimics biophysical processes of natural principals to induce ions in solution to cross the membrane barrier. This mimics how mammal organisms remove wastes from a donor liquid without physically mixing with an acceptor liquid. 

 

The technology has been proven to be effective and efficient during laboratory testing, and in the Board's view, NCX's technology is an innovative approach to direct lithium extraction.

 

Environmental attractions include limited energy and water consumption, extracting the targeted ions and generating minimal waste. It is suited for lithium extraction from Bolivian brines, where evaporative ponds are not optimal due to rainfall conditions, altitude and magnesium content. 

 

Laboratory / bench test analyses extracted ions from solutions at ambient temperatures and pressures - even in very low concentrations.

 

The next step is to test selected brines from potential sources. NCX is assembling, subject to funding being delivered from Clontarf (per the below), a pilot plant in Texas to test large volumes of brines, moving towards feasibility and commercialisation. The plant will test circa 1,000 litres of each specific brine, with an overall 20,000 litre trial run size, allowing a customised NCX DLE commercial system to be assembled (in modular form) and placed on site for field testing.

 

 

The NCX DLE Technology is patent pending, with intellectual property protection managed by Patent Attorneys specialised in chemical processing and materials science.

 

Clontarf is in discussions with Bolivia's state owned lithium company ("YLB") to test NCX's proprietary DLE membrane technology on priority brines, which may include identified salares on which preliminary samples have been taken.

 

Negotiations with the proper authorities covering the source and volumes of brines to be processed, and on which commercial terms, are expected to follow successful pilot plant operation - subject to applicable laws.

The pilot plant testing and extraction will begin during March 2023, including both preliminary testing, as well as pilot plant operations, with results expected by May 2023.

 

 

Heads of Agreement Terms:

 

A 50:50 joint venture company to be formed on completion of due diligence covering the exclusive rights to the marketing, testing and deployment of the NCX DLE technology in Bolivia.

 

Clontarf Energy plc to contribute $500,000 towards the pilot plant construction and testing as an exclusivity fee for the use of the NCX technology.

 

NCX will then issue shares equal to $500,000 at its next financing (CHMX:OTC) to Clontarf Energy plc

 

Clontarf Energy plc will issue shares as follows to NCX:

i. 385 million new Ordinary Shares on proceeding with the Pilot Plant $500,000 contribution from Clontarf;

 

ii. 250 million new Ordinary Shares after successful pilot processing of Bolivian brines through the NCX pilot plant; and

 

iii. 250 million new Ordinary Shares after entry into a construction and processing contract between the JV and the Bolivian authorities on processing of Bolivian brines utilising NCX processing technology.

 

 

NCX, or its nominee, will have the right, but not the obligation, to invest £250,000 into the Company at a price of £0.00065, for 30 days from the signature of this HoA.

 

As noted above, formation of the JV is subject to final due diligence and the parties entering into formal documentation (based on the terms of the Heads of Agreement), which is intended to occur within the next 30 days.

 

Chairman, David Horgan, commented:

 

"The world needs a dramatic increase in battery grade lithium salts output. Projected global demand cannot be delivered without major Bolivian output. The delay has been the shortcomings of evaporative ponds at high altitude, some rainfall and impurity levels.

 

"We believe that these constraints may be bypassed through innovative technology.

 

"In minimising environmental impact, we have worked to reduce water use by 95%, and minimise the footprint of on-site operations.

 

"Any Bolivian operations will conform with applicable laws, in partnership with the State Lithium Company, and respect high international operating standards."

 

ENDS

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

 

 

 

For further information please visit http://clontarfenergy.com or contact:

 

Clontarf Energy

David Horgan, Chairman

Jim Finn, Director

+353 (0) 1 833 2833

Nominated & Financial Adviser

Strand Hanson Limited

Rory Murphy

Ritchie Balmer

+44 (0) 20 7409 3494

Broker

Novum Securities Limited

Colin Rowbury

+44 (0) 207 399 9400

Public Relations

BlytheRay

Megan Ray

+44 (0) 207 138 3206

 

Teneo

Luke Hogg

Alan Tyrrell

 

+353 (0) 1 661 4055

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEEAAALFLKDEAA
Date   Source Headline
19th May 20217:00 amRNSPreliminary Results for the Year Ended 31 Dec 2020
17th May 20214:31 pmRNSTR-1: Notification of major holdings
14th May 202110:40 amRNSNotification of major holdings
6th May 20217:00 amRNSPlacing to raise £500,000
30th Dec 20204:40 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSInterim Statement for period ended 30 June 2020
23rd Jul 202011:32 amRNSResult of AGM
17th Jun 20203:24 pmRNSPosting of Annual Report and Notice of AGM
26th May 20207:00 amRNSPreliminary Results for the Year Ended 31/12/19
3rd Apr 20207:00 amRNSCorporate Update
27th Mar 20204:40 pmRNSSecond Price Monitoring Extn
27th Mar 20204:37 pmRNSPrice Monitoring Extension
27th Mar 20202:00 pmRNSPrice Monitoring Extension
6th Dec 20194:40 pmRNSSecond Price Monitoring Extn
6th Dec 20194:35 pmRNSPrice Monitoring Extension
3rd Dec 20194:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20194:35 pmRNSPrice Monitoring Extension
2nd Dec 20194:35 pmRNSPrice Monitoring Extension
2nd Dec 20192:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20192:01 pmRNSPrice Monitoring Extension
2nd Dec 201911:05 amRNSSecond Price Monitoring Extn
2nd Dec 201911:00 amRNSPrice Monitoring Extension
2nd Dec 20199:05 amRNSSecond Price Monitoring Extn
2nd Dec 20199:00 amRNSPrice Monitoring Extension
29th Nov 20194:40 pmRNSSecond Price Monitoring Extn
29th Nov 20194:35 pmRNSPrice Monitoring Extension
29th Nov 20192:05 pmRNSSecond Price Monitoring Extn
29th Nov 20192:00 pmRNSPrice Monitoring Extension
2nd Oct 20194:00 pmRNSIssue of Share Options
20th Sep 20197:00 amRNSInterim Statement for period ended 30 June 2019
27th Jun 201912:23 pmRNSResults of Annual General Meeting
28th May 20197:00 amRNSPreliminary Results for the Year Ended 31 Dec 2018
30th Apr 20197:00 amRNSAppointment of Non-Executive Director
25th Mar 20194:41 pmRNSSecond Price Monitoring Extn
25th Mar 20194:36 pmRNSPrice Monitoring Extension
16th Jan 20197:00 amRNSChange of Nominated Adviser
2nd Oct 20182:06 pmRNSSecond Price Monitoring Extn
2nd Oct 20182:00 pmRNSPrice Monitoring Extension
1st Oct 201811:05 amRNSSecond Price Monitoring Extn
1st Oct 201811:00 amRNSPrice Monitoring Extension
27th Sep 20187:00 amRNSInterim Results
20th Sep 20182:52 pmRNSPlacing to raise £500,000
20th Sep 201810:01 amRNSLithium Prospecting in Bolivia
17th Sep 20187:00 amRNSTano 2A Block Update
29th Jun 201812:08 pmRNSResult of AGM
15th Jun 20184:41 pmRNSSecond Price Monitoring Extn
15th Jun 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.